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Available online 2 July 2004Aims The purpose of this registry is to collect data on trends in interventional
cardiology within Europe. Special interest focuses on relative increases and ratios in
newer re-vascularisation approaches and its distribution in different regions in
Europe. We report the data of the year 2001 and give an overview of the development
of coronary interventions since 1992, when the first data collection was performed.
Methods and Results Questionnaires were distributed to delegates of the individual
national societies of cardiology represented in the European Society of Cardiology.
These were completed by the local institutions and operators and showed that
1,806,238 angiograms and 617,176 percutaneous transluminal coronary angioplasties
(PTCAs) were performed in 2001. This is an increase of 10% and 17%, respectively,
compared with the year 2000. The population-adjusted PTCA rate rose from nearly
800 procedures per 106 inhabitants in the year 2000 to approximately 990 procedures
per 106 inhabitants in 2001. Coronary stenting increased by 25% to about 488,900
stents implanted in 2001. Complication rates remained unchanged, and the need for
emergency coronary artery bypass grafting is still at 0.2% per percutaneous
intervention.
Conclusion Interventional cardiology in Europe is still expanding, mainly due to rapid
growth in countries with lower socio-economical levels. Most central European
countries reported only minor increases in procedures performed. Coronary stenting
remains the only noteworthy adjunctive strategy to balloon angioplasty.c 2004 The European Society of Cardiology. Published by Elsevier Ltd. All rights
reserved.
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Little reliable data exist which provides field trends in
interventional cardiology.1–4 The report on Interven-
tional Cardiology in Europe in 2001 provides the 10th
edition of yearly reports initiated in 1992.5–13 The aimrdiology. Published by Elsevier Ltd. All rights reserved.
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interventions in Europe over the last 10 years. It
summarises cardiac catheter interventions and gives an
overview of specific interventional cardiological activ-
ities in 29 countries of Europe, the majority of the
members of the European Society of Cardiology.Methods
A detailed questionnaire, together with instructions and ex-
amples for completion, was sent to the presidents or desig-
nated delegates of the national societies of cardiology
represented in the European Society of Cardiology. It was
distributed nationwide to all facilities performing diagnostic
or interventional cardiac catheterisation. A summary data
sheet, filled out by the national representatives, was used to
report the nationwide data set. Finally the data were entered
into the central database and analysed. In the case of missing
or incomplete data, the national representatives were re-
peatedly reminded. In September 2003, the registry was
closed for the 2001 report. Sufficient data were reported from
29 of the 32 countries included in the survey, representing
more than 550 million people. Despite numerous reminders
Bulgaria, Ireland, Morocco did not provide sufficient data to
be included in the survey. Prior to publication, the manuscript
was submitted to the country representatives to have the
figures checked for accuracy. Definitions of pathologies and
procedures, as well as questionnaires, were used according to
previously published reports.8Fig. 1 Coronary angiograms, coronary angioplasty (PTCA), and coronarResults
Coronary angiography
Of the 32 distributed country summaries, 29 were re-
ceived and analysed. A total of 1,806,238 coronary an-
giograms were performed in Europe in 2001 (Fig. 1).
This corresponds to an increase of 10% compared with
2000. In the 10-year period from 1992 to 2001 a 3-fold
increase of coronary angiograms occurred. In 2001,
Germany reported the highest absolute and relative
numbers, namely 611,882 angiograms or 7462 per mil-
lion inhabitants (Fig. 2). This is a relative increase of 2%
compared with 2000. Other central European countries
reported varying increases in population-adjusted angi-
ograms performed: Finland þ30%, Austria þ9%, Italy
þ8%, United Kingdom þ4%, Norway þ3%, Switzerland
þ0.5%. Most of the eastern European countries showed
increases in angiograms per population. Poland reported
the highest rise with 34%, while Slovakia and Latvia
were the only countries with a decrease of )4% and
)5%, respectively.Coronary angioplasty
A total of 617,176 percutaneous transluminal coronary
angioplasty (PTCA) procedures were reported for 2001, a
17% increase compared with 2000 (Fig. 1). Compared
with the annual yearly survey in 1992 this constitutes ay stenting from 1992 to 2001 in Europe in thousands of procedures.
Fig. 2 Coronary angiograms, coronary angioplasty (PTCA), and coronary stenting per 106 inhabitants and country in 2001. A, Austria; B, Belgium; CH,
Switzerland; CY, Cyprus; CZ, Czech Republic; D, Germany; DK, Denmark; E, Spain; EST, Estonia; F, France; GR, Greece; H, Hungary; HR, Croatia; I, Italy;
IS, Iceland; L, Luxembourg; LT, Lithuania; LV, Latvia; N, Norway; NL, Netherlands; P, Portugal; PL, Poland; RO, Romania; S, Sweden; SF, Finland; SK,
Slovak Republic; SLO, Slovenia; TR, Turkey; UK, United Kingdom.
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population-adjusted number in 2001 was nearly 990
procedures per 106 inhabitants, representing an increase
of 24% compared with the year 2000 (about 800 PTCAs
per 106 inhabitants). Germany reported 195,280 PTCAs or
2381 PTCAs per 106 inhabitants, by far the highest
numbers (Fig. 2). Iceland was the only country with a
population-adjusted PTCA rate comparable with Ger-
many with 2065 procedures per 106 inhabitants. The
smallest numbers of procedures per million people were
reported from Romania (98) and Slovakia (233). All
countries reported relative increases in procedures.
There is however an enormous variability with eastern
European countries reporting the highest relative in-
crease (Hungary þ108%, Poland þ53%).
The mean ratio of PTCAs to coronary angiograms was
0.33 (2000: 0.32). The ratio of PTCAs to coronary angi-
ograms ranged from 0.21 in Romania to 0.50 in Iceland
(Fig. 3). Ad hoc PTCA procedure rate reached a share of
52% and the highest ad hoc percentages were reported
from Cyprus (84%), followed by Luxembourg (76%),
Slovenia (76%), and Estonia (75%). From 1992 to 2001 the
share of ad hoc PTCA procedures increased from about
25% to 52% (Fig. 4).Multi-vessel interventions in one session were per-
formed in 18% in 2001. In the 10-year period there is no
clear trend towards a relative increase in multi-vessel
procedures. Interventions for acute myocardial infarc-
tion in 2001 amounted to 15% of all coronary procedures.
These numbers are comparable with those reported by
the National Cardiovascular Data Registry of the Ameri-
can College of Cardiology for 1998 to 2000.3 The 10-year
overview shows an increase of interventions for acute
myocardial infarction per PTCA from 4% to 15% (Fig. 5).
Coronary stenting
Approximately 488,900 stenting procedures were re-
ported in 2001 (Fig. 1), resulting in an increase of 25%
compared with 2000 (approximately 395,000 proce-
dures). Stenting was rare in 1992 with a total of 3211
procedures (six per million) but these procedures tripled
from 1993 to 1994, and quadrupled from 1994 to 1995.
Since 1996 stenting procedures have shown a mean an-
nual increase of 38% and Germany and France reported
the highest absolute numbers for 2001 with 148,157 and
88,424, respectively. The ratio of coronary stenting to
PTCA procedures averaged 0.75 most countries reporting
Fig. 3 PTCAs per coronary angiogram ratio in 2001 in Europe (abbrevi-
ations as in Fig. 2).
Fig. 4 Ad hoc PTCA rate from 1992 to 2001 in Europe.
Fig. 5 PTCA rate for acute myocardial infarction from 1992 to 2001 in
Europe.
Fig. 6 Coronary stenting per PTCA ratio and country in 2001 (abbrevi-
ations as in Fig. 2).
Percutaneous coronary interventions in Europe 1992–2001 1211ratios of 0.70 or above (Fig. 6). Drug-eluting stents were
introduced in 2001 but no systematically collected data
on their use in 2001 is available.
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Other therapeutic devices (directional atherectomy, ro-
tablator, laser or wire catheter, ultrasound therapy,
brachytherapy, cloth catcher/remover) were reported in
a total of 11,416 cases in 2001. There were no sweeping
changes over the last 10 years, and none of the devices
reached the 1% level.
Complications
Myocardial infarction was reported in 1.1% and death in
0.6%. These rates have not changed over the last 10
years, and are in accordance with data from American
registries.3;4 The need for emergency CABG remained
unchanged at 0.2%. This reflects a 10-fold reduction of
the relative need for emergency CABG during the last 10
years (Fig. 7).
Catheterisation facilities
According to the reported numbers, there was a mean of
2.5 cardiac catheterisation facilities per 106 inhabitants
in Europe. In the previous year, there were 2.8 with the
highest density existing in Iceland (7.3 per 106) and the
lowest in Romania (0.35 per 106). A mean of 1019
(565–1852) diagnostic procedures per catheterisation
room and 325 angioplasties (188–519) per catheterisa-
tion room were performed. The number of diagnostic
operators per million people ranged between 2 in Ro-
mania and 44 in Iceland, and the coverage with PCI op-
erators per million people ranged from 1 in Romania to
16 in Switzerland.Fig. 7 Complication rates (%) of coronary inDiscussion
The Interventional Cardiology and Coronary Pathophysi-
ology working group of the European Society of Cardiol-
ogy has been conducting an annual survey of cardiac
interventions since 1992.5–13 This report summarises the
data reported for 2001 and shows the development of
interventional cardiology in Europe from 1992 to 2001.
Sufficient data for the year 2001 were reported from 29
countries, representing 550 million people in Europe.
The information provided by the national societies of
cardiology was voluntary and not scrutinised and no audit
or quality control was performed. Therefore, the data
are aggregated, retrospective and under-reporting of
complications is very likely.
In 2001, a total of 1,806,238 diagnostic procedures
and 617,176 PTCAs were reported, corresponding to an
increase of 10% and 17%, respectively, compared with
the year 2000. The proportional rise in PTCA procedures
was slightly higher than the rise in angiographies result-
ing in a rise of the PTCA to coronary angiography ratio
from 0.32 in 2000 to 0.33 in 2001. The angiography
numbers are still increasing throughout the European
community. For the PTCA procedures there is a marked
difference between the different nations, with eastern
European countries reporting the highest increases. The
only northern and central European countries reporting
high rises in PTCA procedure-rates are Norway and Spain
(þ34% and þ31%, respectively). Spain has lagged behind
the other western European countries in the past years
but it is probable that this country is reaching rates
comparable to countries with similar gross national
products.terventions from 1992 to 2001 in Europe.
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reached a plateau. This is surprising considering the
change in attitude to the technique by both physicians
and patients. Logistical, and perhaps political, reasons
must account for the slow progress of the logical com-
bination of diagnostic and therapeutic catheterisation.
Some countries had passed the 80% level already the
years ago.
The percentage of multi-vessel PTCAs was 18%. Multi-
vessel PTCA rate has shown a slight increase during the
past years. This is in contrast with the general opinion
that the introduction of stents has led to a substantial
increase in multi-vessel PTCAs. The percentage of staged
multi-vessel procedures is not known. It will be inter-
esting to observe the impact of drug-eluting stents on
multi-vessel PTCAs.14
Major complication rates for PTCA have remained
unchanged and the need for emergency CABG has further
declined. As pointed out previously, under-reporting of
complications is very likely due to the missing audit and
quality control.
It is encouraging to see the percentage of interven-
tions for acute myocardial infarction rise to 15%. This
might reflect the assimilation of the results of the PRA-
GUE, PRAGUE-2 and DANAMI-2 trials,15–17 which favoured
primary angioplasty over thrombolysis for acute myo-
cardial infarction, even when transportation to a tertiary
angioplasty centre is necessary. This trend is likely to
continue over the next years.
The reported number of coronary stenting procedures
showed an increase of 25% from 391,000 in 2000 to
488,900 in 2001. Coronary stents were applied in 72% of
coronary angioplasties. Central and western European
countries used more stents, and their stenting rate went
as high as 96% in France. Each country included in the
survey reported an increase in the use of stents from
2000 to 2001.
In 2001, drug-eluting stents have been used only
sporadically. It remains to be seen if this new device will
have any impact on the overall numbers of procedures in
the next year or whether it has a greater impact on the
number of complex cases.18Appendix
We express our thanks to all representatives of the na-
tional societies of cardiology and the local persons put in
charge in the individual centres for their highly appre-
ciated help with this data collection. Following an al-
phabetical list of the principal data coordinators of each
country that participated in this survey:
Austria: M€uhlberger V. Belgium: Heyndrickx G. Croa-
tia: Mihatov S. Cyprus: Zambartas C. Czech Republic:
Vojacek J. Denmark: Thayssen P. Germany: Mannebach
H. Spain: Hernandez JM. Estonia: Peeba L. Finland:
Ropponen L. France: Lablanche JM. Greece: Lazaris E.Hungary: Pasztelyi Z. Iceland: Eyjolfsson K. Italy: Pisci-
one F. Latvia: Erglis A. Lithuania: Navickas R. Luxem-
bourg: Beissel J. Netherlands: Suttorp MJ. Norway:
Melberg T. Poland: Witkowski A. Portugal: Goncalves M.
Romania: Capalneanu R. Switzerland: Eeckhout E. Slo-
vakia: Fridrich V. Slovenia: Cijan A. Sweden: Nilsson T.
Turkey: €Ozmen F. United Kingdom: De Belder MA.References
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